Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1989 Jul;48(7):571–576. doi: 10.1136/ard.48.7.571

Crystal deposition in hypophosphatasia: a reappraisal.

A J Chuck 1, M G Pattrick 1, E Hamilton 1, R Wilson 1, M Doherty 1
PMCID: PMC1003818  PMID: 2549888

Abstract

Six subjects (three female, three male; age range 38-85 years) with adult onset hypophosphatasia are described. Three presented atypically with calcific periarthritis (due to apatite) in the absence of osteopenia; two had classical presentation with osteopenic fracture; and one was the asymptomatic father of one of the patients with calcific periarthritis. All three subjects over age 70 had isolated polyarticular chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition; four of the six had spinal hyperostosis, extensive in two (Forestier's disease). The apparent paradoxical association of hypophosphatasia with calcific periarthritis and spinal hyperostosis is discussed in relation to the known effects of inorganic pyrophosphate on apatite crystal nucleation and growth.

Full text

PDF
571

Images in this article

573Image
on p.573
573Image
on p.573
574Image
on p.574

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkins C. J., McIvor J., Smith P. M., Hamilton E., Williams R. Chondrocalcinosis and arthropathy: studies in haemochromatosis and in idiopathic chondrocalcinosis. Q J Med. 1970 Jan;39(153):71–82. [PubMed] [Google Scholar]
  2. Buckwalter J. A. Proteoglycan structure in calcifying cartilage. Clin Orthop Relat Res. 1983 Jan-Feb;(172):207–232. [PubMed] [Google Scholar]
  3. Caswell A., Guilland-Cumming D. F., Hearn P. R., McGuire M. K., Russell R. G. Pathogenesis of chondrocalcinosis and pseudogout. Metabolism of inorganic pyrophosphate and production of calcium pyrophosphate dihydrate crystals. Ann Rheum Dis. 1983 Aug;42 (Suppl 1):27–37. doi: 10.1136/ard.42.suppl_1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dodds W. J., Steinbach H. L. Primary hyperparathyroidism and articular cartilage calcification. Am J Roentgenol Radium Ther Nucl Med. 1968 Dec;104(4):884–892. doi: 10.2214/ajr.104.4.884. [DOI] [PubMed] [Google Scholar]
  5. Doherty M., Dieppe P. Crystal deposition disease in the elderly. Clin Rheum Dis. 1986 Apr;12(1):97–116. [PubMed] [Google Scholar]
  6. Eade A. W., Swannell A. J., Williamson N. Pyrophosphate arthropathy in hypophosphatasia. Ann Rheum Dis. 1981 Apr;40(2):164–170. doi: 10.1136/ard.40.2.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Einhorn T. A., Gordon S. L., Siegel S. A., Hummel C. F., Avitable M. J., Carty R. P. Matrix vesicle enzymes in human osteoarthritis. J Orthop Res. 1985;3(2):160–169. doi: 10.1002/jor.1100030205. [DOI] [PubMed] [Google Scholar]
  8. FLEISCH H., BISAZ S. Isolation from urine of pyrophosphate, a calcification inhibitor. Am J Physiol. 1962 Oct;203:671–675. doi: 10.1152/ajplegacy.1962.203.4.671. [DOI] [PubMed] [Google Scholar]
  9. Feller E. R., Schumacher H. R. Osteoarticular changes in Wilson's disease. Arthritis Rheum. 1972 May-Jun;15(3):259–266. doi: 10.1002/art.1780150307. [DOI] [PubMed] [Google Scholar]
  10. Fernley H. N., Walker P. G. Studies on alkaline phosphatase. Inhibition by phosphate derivatives and the substrate specificity. Biochem J. 1967 Sep;104(3):1011–1018. doi: 10.1042/bj1041011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fleisch H., Straumann F., Schenk R., Bisaz S., Allgöwer M. Effect of condensed phosphates on calcification of chick embryo femurs in tissue culture. Am J Physiol. 1966 Sep;211(3):821–825. doi: 10.1152/ajplegacy.1966.211.3.821. [DOI] [PubMed] [Google Scholar]
  12. Forestier J., Lagier R. Ankylosing hyperostosis of the spine. Clin Orthop Relat Res. 1971 Jan;74:65–83. [PubMed] [Google Scholar]
  13. Gerster J. C., Baud C. A., Lagier R., Boussina I., Fallet G. H. Tendon calcifications in chondrocalcinosis. A clinical, radiologic, histologic, and crystallographic study. Arthritis Rheum. 1977 Mar;20(2):717–722. doi: 10.1002/art.1780200212. [DOI] [PubMed] [Google Scholar]
  14. Gerster J. C., Lagier R., Boivin G. Olecranon bursitis related to calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum. 1982 Aug;25(8):989–996. doi: 10.1002/art.1780250812. [DOI] [PubMed] [Google Scholar]
  15. Hamilton E. B., Bomford A. B., Laws J. W., Williams R. The natural history of arthritis in idiopathic haemochromatosis: progression of the clinical and radiological features over ten years. Q J Med. 1981 Summer;50(199):321–329. [PubMed] [Google Scholar]
  16. Hsu H. H., Anderson H. C. The deposition of calcium pyrophosphate and phosphate by matrix vesicles isolated from fetal bovine epiphyseal cartilage. Calcif Tissue Int. 1984 Sep;36(5):615–621. doi: 10.1007/BF02405376. [DOI] [PubMed] [Google Scholar]
  17. Leisen J. C., Austad E. D., Bluhm G. B., Sigler J. W. The tophus in calcium pyrophosphate deposition disease. JAMA. 1980 Oct 10;244(15):1711–1712. [PubMed] [Google Scholar]
  18. Macfarlane J. D., Kroon H. M., Cats A. Ectopic calcification in hypophosphatasia. Eur J Radiol. 1986 Aug;6(3):228–230. [PubMed] [Google Scholar]
  19. McGuire M. B., Colman C. H., Baghat N., Russell R. G. Radiometric measurement of pyrophosphate in cell cultures. Biochem Soc Trans. 1980 Oct;8(5):529–530. doi: 10.1042/bst0080529. [DOI] [PubMed] [Google Scholar]
  20. Milazzo S. C., Ahern M. J., Cleland L. G., Henderson D. R. Calcium pyrophosphate dihydrate deposition disease and familial hypomagnesemia. J Rheumatol. 1981 Sep-Oct;8(5):767–771. [PubMed] [Google Scholar]
  21. O'Duffy J. D. Hypophosphatasia associated with calcium pyrophosphate dihydrate deposits in cartilage. Report of a case. Arthritis Rheum. 1970 Jul-Aug;13(4):381–388. doi: 10.1002/art.1780130404. [DOI] [PubMed] [Google Scholar]
  22. Paul H., Reginato A. J., Schumacher H. R. Alizarin red S staining as a screening test to detect calcium compounds in synovial fluid. Arthritis Rheum. 1983 Feb;26(2):191–200. doi: 10.1002/art.1780260211. [DOI] [PubMed] [Google Scholar]
  23. Pimstone B., Eisenberg E., Silverman S. Hypophosphatasia: genetic and dental studies. Ann Intern Med. 1966 Oct;65(4):722–729. doi: 10.7326/0003-4819-65-4-722. [DOI] [PubMed] [Google Scholar]
  24. Pinquier J. L., Awada H., Delrieu F., Amor B. Chondrocalcinose isolée révélant une hypophosphatasie de l'adulte. Deux observations et revue de la littérature. Rev Rhum Mal Osteoartic. 1987 Jun;54(6):501–504. [PubMed] [Google Scholar]
  25. Pritchard M. H., Jessop J. D. Chondrocalcinosis in primary hyperparathyroidism. Influence of age, metabolic bone disease, and parathyroidectomy. Ann Rheum Dis. 1977 Apr;36(2):146–151. doi: 10.1136/ard.36.2.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. RUSSELL R. G. EXCRETION OF INORGANIC PYROPHOSPHATE IN HYPOPHOSPHATASIA. Lancet. 1965 Sep 4;2(7410):461–464. doi: 10.1016/s0140-6736(65)91422-4. [DOI] [PubMed] [Google Scholar]
  27. Resnick D., Shapiro R. F., Wiesner K. B., Niwayama G., Utsinger P. D., Shaul S. R. Diffuse idiopathic skeletal hyperostosis (DISH) [ankylosing hyperostosis of Forestier and Rotes-Querol]. Semin Arthritis Rheum. 1978 Feb;7(3):153–187. doi: 10.1016/0049-0172(78)90036-7. [DOI] [PubMed] [Google Scholar]
  28. Resnick D., Shaul S. R., Robins J. M. Diffuse idiopathic skeletal hyperostosis (DISH): Forestier's disease with extraspinal manifestations. Radiology. 1975 Jun;115(3):513–524. doi: 10.1148/15.3.513. [DOI] [PubMed] [Google Scholar]
  29. Runeberg L., Collan Y., Jokinen E. J., Lähdevirta J., Aro A. Hypomagnesemia due to renal disease of unknown etiology. Am J Med. 1975 Dec;59(6):873–881. doi: 10.1016/0002-9343(75)90481-7. [DOI] [PubMed] [Google Scholar]
  30. Russell R. G., Bisaz S., Donath A., Morgan D. B., Fleisch H. Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta, and other disorders of bone. J Clin Invest. 1971 May;50(5):961–969. doi: 10.1172/JCI106589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Russell R. G., Fleisch H. Pyrophosphate and diphosphonates in skeletal metabolism. Physiological, clinical and therapeutic aspects. Clin Orthop Relat Res. 1975 May;(108):241–263. doi: 10.1097/00003086-197505000-00038. [DOI] [PubMed] [Google Scholar]
  32. Russell R. G. Metabolism of inorganic pyrophosphate (PPi). Arthritis Rheum. 1976 May-Jun;19 (Suppl 3):465–478. doi: 10.1002/1529-0131(197605/06)19:3+<465::aid-art1780190722>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  33. Schumacher H. R., Jr, Bonner H., Thompson J. J., Kester W. L., Benner J. J., 4th Tumor-like soft tissue swelling of the distal phalanx due to calcium pyrophosphate dihydrate crystal deposition. Arthritis Rheum. 1984 Dec;27(12):1428–1432. doi: 10.1002/art.1780271215. [DOI] [PubMed] [Google Scholar]
  34. Siegel S. A., Hummel C. F., Carty R. P. The role of nucleoside triphosphate pyrophosphohydrolase in in vitro nucleoside triphosphate-dependent matrix vesicle calcification. J Biol Chem. 1983 Jul 25;258(14):8601–8607. [PubMed] [Google Scholar]
  35. Turnell D. C., Cooper J. D. Rapid assay for amino acids in serum or urine by pre-column derivatization and reversed-phase liquid chromatography. Clin Chem. 1982 Mar;28(3):527–531. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES